The Persistence of Refractory Pharmaceuticals in Aquatic Systems and Their Environmental Impacts

Authors

  • Xingqi Sheng

DOI:

https://doi.org/10.54097/h8qexd87

Keywords:

Pharmaceutical removal, waste water, Environmental risks, Photocatalysis.

Abstract

This study investigates the occurrence and persistence of pharmaceutical residues in wastewater, with particular emphasis on treatment methods including nanofiltration, microbial biodegradation, constructed wetlands, and titanium dioxide (TiO₂) photocatalysis. Most of these approaches achieve elimination rates exceeding 70% for specific pharmaceuticals. However, notable limitations remain: microbial biodegradation is highly sensitive to environmental factors such as temperature, pH, and nutrient availability, leading to variability across seasons and locations; TiO₂ photocatalysis requires ultraviolet light excitation and is hindered by light scattering, shielding effects, and interference from natural organic matter and inorganic ions. These findings underscore the urgent need for more robust and scalable solutions to mitigate the environmental risks posed by pharmaceutical contamination in aquatic systems.

Downloads

Download data is not yet available.

References

[1] Ternes, Thomas A., et al. "Removal of pharmaceuticals during drinking water treatment." Environmental Science & Technology 36.17 (2002): 3855-3863. 10.1021/es015757k

[2] Patel M, Kumar R, Kishor K, et al. Pharmaceuticals of emerging concern in aquatic systems: chemistry, occurrence, effects, and removal methods [J]. Chemical Reviews, 2019, 119 (6): 3510-3673.

[3] Li, Y.; Zhu, G.; Ng, W. J.; Tan, S. K. A review on removing pharmaceutical contaminants from wastewater by constructed wetlands: design, performance and mechanism. Science of the Total Environment, 2014, 468: 908−932.

[4] Kanakaraju, Devagi, Beverley D. Glass, and Michael Oelgemöller. "Titanium dioxide photocatalysis for pharmaceutical wastewater treatment." Environmental Chemistry Letters 12.1 (2014): 27-47.

[5] Parimal, Al. "Treatment and disposal of pharmaceutical wastewater: toward the sustainable strategy." Separation & Purification Reviews 47.3 (2018): 179-198.

[6] Künnemeyer, J., Terborg, L., Meermann, B., Brauckmann, C., Möller, I., Scheffer, A., and Karst, U. "Speciation analysis of gadolinium chelates in hospital effluents and wastewater treatment plant sewage by a novel HILIC/ICP-MS method." Environmental Science & Technology 43.8 (2009): 2884–2890.

[7] Jean, J., Perrodin, Y., Pivot, C., Trepo, D., Perraud, M., Droguet, J., Tissot-Guerraz, F., and Locher, F. "Identification and prioritization of bioaccumulable pharmaceutical substances discharged in hospital effluents." Journal of Environmental Management 103 (2012): 113-121.

[8] Camacho-Muñoz, D., Martín, J., Santos, J. L., Aparicio, I., and Alonso, E. "Effectiveness of conventional and low-cost wastewater treatments in the removal of pharmaceutically active compounds." Water, Air, & Soil Pollution 223 (2012): 261-121.

Downloads

Published

18-11-2025

Issue

Section

Articles

How to Cite

Sheng, X. (2025). The Persistence of Refractory Pharmaceuticals in Aquatic Systems and Their Environmental Impacts. International Journal of Energy, 8(1), 100-104. https://doi.org/10.54097/h8qexd87